| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating | 
|---|
 
																	 
																	bioAffinity Technologies' stock surged after a patent notice and Nasdaq compliance update but slipped in after-hours trading.
 
																	SAN ANTONIO, Texas--(BUSINESS WIRE)-- bioAffinity Technologies, Inc. (NASDAQ:BIAF, BIAFW)), a biotechnology company advancing e...
 
																	
 
																	 
																	bioAffinity Technologies shares surged over 20% pre-market following a strong third-quarter sales update for its lung cancer di...
 
																	bioAffinity Technologies, Inc. (NASDAQ:BIAF, BIAFW)),a biotechnology company advancing noninvasive diagnostics for lung cancer ...
 
																	
